|
| Home - Fachinformation zu Relvar Ellipta 92/22 mcg - Änderungen - 02.02.2026 | |
| 8 Änderungen an Fachinfo Relvar Ellipta 92/22 mcg |
-Behandlung [Ereignisrate pro
- +Behandlung [Ereignisrate pro
-FF/VI 92/22N=4140 FF 92N=4157 VI 22N=4140 PlaceboN=4131
-Pneumonie 237 (6)[39.5] 228 (5)[42.4] 163 (4)[27.7] 214 (5)[38.4]
-Schwere Pneumonie 140 (3)[22.4] 146 (4)[25.1] 104 (3)[16.4] 127 (3)[22.2]
-Todesfälle infolge 13 (<1)[1.8] 10 (<1)[1.5] 6 (<1)[0.9] 9 (<1)[1.4]
- +FF/VI 92/22 N=4140 FF 92 N=4157 VI 22 N=4140 Placebo N=4131
- +Pneumonie 237 (6) [39.5] 228 (5) [42.4] 163 (4) [27.7] 214 (5) [38.4]
- +Schwere Pneumonie 140 (3) [22.4] 146 (4) [25.1] 104 (3) [16.4] 127 (3) [22.2]
- +Todesfälle infolge 13 (<1) [1.8] 10 (<1) [1.5] 6 (<1) [0.9] 9 (<1) [1.4]
-Behandlung [Ereignisrate pro
- +Behandlung [Ereignisrate pro
-FF/VI 92/22N=4140 FF 92N=4157 VI 22N=4140 PlaceboN=4131
-Alle Frakturen 82 (2)[13.6] 66 (2)[12.8] 74 (2)[13.2] 69 (2)[11.5]
-Frakturen häufig in 23 (<1)[3.4] 24 (<1)[3.9] 17 (<1)[2.4] 13 (<1)[2.1]
- +FF/VI 92/22 N=4140 FF 92 N=4157 VI 22 N=4140 Placebo N=4131
- +Alle Frakturen 82 (2) [13.6] 66 (2) [12.8] 74 (2) [13.2] 69 (2) [11.5]
- +Frakturen häufig in 23 (<1) [3.4] 24 (<1) [3.9] 17 (<1) [2.4] 13 (<1) [2.1]
|
|
|